Sparsentan may be a new treatment option for focal segmental glomerulosclerosis

  • Post author:
  • Post category:uncategorized

Focal segmental glomerulosclerosis (FSGS) is a rare kidney disorder that affects children and adults, and can lead to kidney failure.